ClinicalTrials.gg
RecruitingNCT07841119Updated Nov 18, 2026

Gingival Depigmentation Using a 940 nm Diode Laser Versus Ceramic Bur

An interventional study of 940 nm GaAlAs Diode Laser and Ceramic Soft Tissue Trimmer in Physiologic Gingival Melanin Pigmentation, sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. Recruiting at 1 site in Vietnam. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by University of Medicine and Pharmacy at Ho Chi Minh City · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Updated Nov 18, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized split-mouth clinical trial will compare the effectiveness of a 940 nm GaAlAs diode laser and a ceramic soft tissue trimmer for the treatment of physiologic gingival melanin pigmentation. Each participant will receive both treatment modalities in separate gingival regions according to a randomized allocation. Changes in gingival pigmentation will be evaluated using clinical pigmentation indices and digital image analysis. Participants will be followed at 1, 3, and 6 months after treatment to assess pigmentation reduction and repigmentation.

Read the detailed description

Physiologic gingival melanin pigmentation may affect smile aesthetics and may be treated using several depigmentation techniques. This study is designed as a randomized split-mouth clinical trial comparing a 940 nm GaAlAs diode laser (Epic X, BIOLASE) with a ceramic soft tissue trimmer for gingival depigmentation.

Eligible participants with physiologic gingival melanin pigmentation will receive both interventions in paired gingival regions. Treatment allocation will be randomized. Clinical and photographic assessments will be performed at baseline and during follow-up visits at 1, 3, and 6 months. Gingival pigmentation will be evaluated based on pigmentation intensity and the extent of pigmented gingival area. The study will also assess the persistence or recurrence of pigmentation during follow-up.

02

Conditions studied

  • Physiologic Gingival Melanin Pigmentation

Keywords

  • Gingival depigmentation
  • Gingival melanin pigmentation
  • Diode laser
  • Ceramic soft tissue trimmer
  • Split-mouth randomized clinical trial
03

In context

Lead sponsor

University of Medicine and Pharmacy at Ho Chi Minh City is the lead sponsor of 129 studies on the registry; 45 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or older.
  • Periodontal health, with gingival index (GI) ≤1, bleeding on probing (BOP) ≤10%, probing depths ≤3 mm, and no periodontitis.
  • Thick gingival phenotype with moderate to severe physiologic melanin pigmentation, corresponding to DOPI scores of 2-3, affecting the facial gingiva of the anterior and premolar regions bilaterally.
  • Good oral hygiene, with plaque index (PI) ≤1 and calculus index (CI) ≤1.

Exclusion criteria

Exclusion Criteria:

  • Thin gingival phenotype at the treatment sites.
  • Uncontrolled systemic diseases, including cardiovascular disease, hypertension, or diabetes mellitus.
  • Pregnancy or lactation.
  • Use of medications or presence of conditions affecting hemostasis or wound healing.
  • Oral pigmentation attributable to causes other than physiologic melanin pigmentation, including metallic pigmentation, amalgam tattoo, traumatic tattoo, or pigmentation associated with malignant conditions.
  • Use of medications or chemical agents known to induce oral pigmentation, including antimalarial drugs, minocycline, ketoconazole, or oral .
  • Current smoking.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
17 participants (estimated)

Study arms

  • Experimental
    Laser group

    Gingival depigmentation is performed in one randomly assigned gingival region using a 940 nm GaAlAs diode laser (EpicX, Biolase).

    Device: 940 nm GaAlAs Diode Laser

  • Active comparator
    Ceramic Bur Group

    Gingival depigmentation is performed in the contralateral gingival region using a ceramic soft tissue trimmer (NTI).

    Device: Ceramic Soft Tissue Trimmer

Interventions

  • Device940 nm GaAlAs Diode Laser

    Gingival depigmentation is performed using a 940 nm GaAlAs diode laser (EPIC X, BIOLASE) according to the study protocol.

    Also known as: EPIC X (BIOLASE)

  • DeviceCeramic Soft Tissue Trimmer

    Gingival depigmentation is performed using a ceramic soft tissue trimmer (NTI) according to the study protocol.

    Also known as: NTI Tissue Trimmer

06

What researchers measure

Primary outcomes

  1. Change in Dummett Oral Pigmentation Index (DOPI)

    Gingival pigmentation intensity is assessed using the Dummett Oral Pigmentation Index (DOPI), scored from 0 to 3: score 0 = no clinical pigmentation, with pink gingiva; score 1 = mild pigmentation, characterized by light-brown gingiva; score 2 = moderate pigmentation, characterized by medium-brown or mixed pink and brown gingiva; and score 3 = heavy pigmentation, characterized by deep-brown or bluish-black gingiva. Higher scores indicate greater gingival pigmentation intensity. DOPI scores are compared between gingival regions treated with the 940 nm diode laser and the ceramic soft tissue trimmer over follow-up.

    Time frame: Baseline, 1 month, 3 months, and 6 months after treatment

  2. Change in Pigmented Gingival Area

    The pigmented gingival area is quantified from standardized clinical photographs using digital image analysis and expressed as the percentage of the total gingival area showing melanin pigmentation. Changes are compared between the two treatment modalities over follow-up.

    Time frame: Baseline, 1 month, 3 months, and 6 months after treatment

  3. Extent of Gingival Pigmentation According to the Ponnaiyan Classification

    The extent and distribution of gingival melanin pigmentation are assessed according to the Ponnaiyan classification (2013), which categorizes pigmentation into six types based on the gingival areas involved: Type I, pigmentation limited to the attached gingiva; Type II, pigmentation involving the attached gingiva and interdental papillae; Type III, pigmentation involving the attached gingiva, marginal gingiva, and interdental papillae; Type IV, pigmentation limited to the marginal gingiva; Type V, pigmentation limited to the interdental papillae; and Type VI, pigmentation involving the marginal gingiva and interdental papillae. Changes in Ponnaiyan classification are compared between gingival regions treated with the 940 nm diode laser and the ceramic soft tissue trimmer during follow-up.

    Time frame: Baseline, 1 month, 3 months, and 6 months after treatment

Secondary outcomes

  1. Surgical Procedure Time

    The duration of each gingival depigmentation procedure is recorded in minutes from the beginning to the completion of treatment for the assigned gingival region.

    Time frame: During the surgical procedure

  2. Perioperative Bleeding

    Bleeding is assessed during the gingival depigmentation procedure and at 1 day after treatment using the Varghese bleeding scale. Bleeding is scored as follows: score 0 = no bleeding, with the surgical site clean and dry; score 1 = slight oozing, with blood present but not spreading; and score 2 = evident bleeding, with sufficient blood flow to fill the oral cavity. Bleeding scores are compared between gingival regions treated with the 940 nm diode laser and the ceramic soft tissue trimmer.

    Time frame: During the surgical procedure and 1 day after treatment

  3. Postoperative Pain

    Postoperative pain is assessed using a 10-cm Visual Analogue Scale (VAS), where 0 cm represents no pain and 10.0 cm represents unbearable pain. Pain intensity is categorized as follows: 0 = no pain; 0.1-3.0 cm = mild pain; 3.1-6.0 cm = moderate pain; and 6.1-10.0 cm = severe pain. VAS scores are compared between gingival regions treated with the 940 nm diode laser and the ceramic soft tissue trimmer.

    Time frame: 1, 3, and 7 days after treatment

  4. Gingival Epithelialization

    Epithelialization of the treated gingival surface is clinically assessed based on the presence and extent of epithelial coverage. Epithelialization is compared between gingival regions treated with the 940 nm diode laser and the ceramic soft tissue trimmer.

    Time frame: 3 and 7 days after treatment

  5. Patient Satisfaction

    Patient satisfaction with the gingival esthetic treatment outcome is assessed using a 5-point Likert scale ranging from very dissatisfied to very satisfied.

    Time frame: 6 months after treatment

  6. Number of Gingival Units With Residual or Recurrent Pigmentation

    Gingival Units With Residual or Recurrent Pigmentation The number of gingival units showing residual or recurrent melanin pigmentation is recorded for each treatment modality during follow-up.

    Time frame: 1 month, 3 months, and 6 months after treatment

  7. Willingness to Repeat Gingival Esthetic Treatment

    Repeat Gingival Esthetic Treatment Participants are asked whether they would be willing to undergo the gingival esthetic procedure again if needed. Responses are recorded as Yes or No.

    Time frame: 6 months after treatment

  8. Preferred Treatment Modality

    Participants are asked which treatment modality they would prefer if gingival depigmentation were repeated: diode laser or ceramic soft tissue trimmer.

    Time frame: 6 months after treatment

07

Study locations

1 of 1 sites recruiting
  • Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City
    Ho Chi Minh City, Ho Chi Minh City 749000, Vietnam
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2026 (actual). Primary completion is estimated for Mar 2027, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 19, 2026
First posted
Sep 25, 2026
StartActual
Sep 20, 2026
Primary completionEst.
Mar 31, 2027
CompletionEst.
Apr 30, 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 18, 2026
Sites
Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City is now Recruiting
Nov 18, 2026
Registered
First appeared on the registry
Sep 25, 2026
Show all 2 updates
  1. Nov 18, 2026
    Not yet recruiting→Recruiting
    Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City is now Recruiting
    + 2 other changes: verification date and date precision
  2. Sep 25, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07841119
Responsible party
Huy Gia Ho (Postgraduate Resident, Department of Periodontics, Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City) — Principal investigator
First posted
Sep 25, 2026
Start date
Sep 20, 2026
Primary completion
Mar 31, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Huy Gia Ho, DDS
Contact
ghuygl@gmail.com
+84942560496

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion